Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Septerna (SEPN) Cash from Investing Activities (2023 - 2026)

Septerna's quarterly Cash from Investing Activities came in at -$23.8 million in Q1 2026, down 388.65% year-on-year from $8.3 million in Q1 2025, and up 87.15% quarter-over-quarter from -$185.3 million in Q4 2025.

Septerna has reported Cash from Investing Activities for 4 years, with the latest figure at -$23.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 388.65% year-over-year to -$23.8 million; the trailing twelve-month figure through Mar 2026 stood at -$248.3 million (down 41.85% YoY), and the FY2025 full-year result was -$229.4 million, down 42.81% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$23.8 million, up from -$185.3 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $9.6 million in Q1 2024, with the low at -$185.3 million in Q4 2025.
  • Average Cash from Investing Activities over 4 years is -$41.5 million, with a median of -$18.0 million recorded in 2024.
  • Year-over-year, Cash from Investing Activities sank 10653.75% in 2024 and soared 93.52% in 2025.
  • Tracing SEPN's Cash from Investing Activities over 4 years: stood at -$1.2 million in 2023, then slumped by 10653.75% to -$133.2 million in 2024, then plunged by 39.07% to -$185.3 million in 2025, then soared by 87.15% to -$23.8 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$23.8 million (Q1 2026), -$185.3 million (Q4 2025), and -$38.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -2.89 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 638.50 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -431.90 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -428.90 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -25.54 Mn
10 Septerna 1.34 Bn 1.34 Bn - -23.82 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -23.82 Mn
Mar 31, 2026 -23.82 Mn
Dec 31, 2025 -185.30 Mn
Dec 31, 2025 -185.30 Mn
Sep 30, 2025 -38.39 Mn
Sep 30, 2025 -38.39 Mn
Jun 30, 2025 -786,000.00
Jun 30, 2025 -786,000.00
Mar 31, 2025 -4.87 Mn
Mar 31, 2025 -4.87 Mn
Dec 31, 2024 -133.24 Mn
Dec 31, 2024 -133.24 Mn
Sep 30, 2024 -24.79 Mn
Sep 30, 2024 -24.79 Mn
Jun 30, 2024 -12.13 Mn
Jun 30, 2024 -12.13 Mn
Mar 31, 2024 9.57 Mn
Mar 31, 2024 9.57 Mn
Dec 31, 2023 -1.24 Mn
Dec 31, 2023 -1.24 Mn